BIO vs GMED
Bio-Rad Laboratories Inc · Globus Medical
Relative return (rebased to 100)
Key stats
| Metric | BIO | GMED |
|---|---|---|
| Price | $370.48 | $72.30 |
| Market Cap | $10.25B | $9.71B |
| P/E | 13.49 | 18.05 |
| P/B | 1.35 | 2.02 |
| P/S | 3.97 | 3.30 |
| ROE | 10.0% | 11.2% |
| Net Margin | 29.4% | 18.3% |
| Gross Margin | 51.9% | 34.7% |
| Revenue Growth | 0.7% | 16.7% |
| Dividend Yield | — | — |
| EPS | $27.46 | $4.01 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.